Drug recall · August 1, 2018
Enalapril Maleate recall
Why: Out-of-specification results for the Enalapril Diketopiperazine degradation product during commercial stability.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Enalapril Maleate, USP 5MG, 90-count bottle, RX only. Packaged By: Aidarex Pharmaceuticals. Mfg: Wockhardt Ltd. India. NDC: 33261-0693-90
- Lots / codes
Lots: 51904-1, EXP: 01/31/2018; 51904-4, 52885-1, EXP: 03/31/2018; 52885-3, EXP: 04/30/2018; 52885-4,EXP: 05/28/2018; 53840-2,EXP: 5/28/2018; 53840-3, EXP:6/30/2018; 53840-4, EXP:8/31/2018; 56665-1, EXP: 01/31/2019; 58596-1, EXP: 05/28/2019.
- Quantity
- 61, 90-count bottles
- Company
- Aidarex Pharmaceuticals LLC, Corona, CA
- Distribution
- Distributed Nationwide in the USA
- Initiated
- June 27, 2018 · Voluntary: Firm initiated
- Classified
- July 25, 2018
- Reported
- August 1, 2018
- Ended
- December 4, 2019
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Enalapril
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.